medline.ch Gastroenterologie Gallenwege Neoplasie

	Characteristics of Previously Undetected or Newly Emerging Cholangiocarcinoma Detected by Ultrasound Surveillance in an Endemic Area. Asian Pac J Cancer Prev Promrach N, Nuangchamnong N, Chonyuen S, Seetasarn J, Hiranrat P, Waongenngarm P, Siripongsakun S. PMID: 42663225 [PubMed - indexed for MEDLINE]
	Mendelian Randomization Using a Japanese GWAS Identifies an HLA-Linked Causal Effect of Chronic Hepatitis B on Cholangiocarcinoma Risk. Asian Pac J Cancer Prev Elgeshy K, Nagaoka K, Yamazaki H, Honda M, Nagaoka M, Mizuta T, Toyota T, Maeda D, Kurano S, Tanaka K, Narahara S, Inada H, Tokunaga T, Iio E, Watanabe T, Setoyama H, Uojima H, Tanaka Y. PMID: 42663213 [PubMed - indexed for MEDLINE]
	miR-1294 Upregulation as a Diagnostic Biomarker for Cholangiocarcinoma. Asian Pac J Cancer Prev Supradit K, Phanaksri T, Prasopdee S, Tangphatsornruang S, Sangsrakru D, Wongprasert K, Pholhelm M, Butthongkomvong K, Kulsantiwong J, Kunjantarachot A, Thitapakorn V. PMID: 42663208 [PubMed - indexed for MEDLINE]
	Mendelian Randomization and Single-Cell Transcriptomic Analyses Implicate PPP1R1B as a Risk Factor of Intrahepatic Cholangiocarcinoma. Genes (Basel) Chen Z, Cao F, Li Z. PMID: 42650061 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer. Cancer Med Yang Y, Wu Z, Zhu Y, Zhang Y, Zhou Z, Song X, Yang Z, Liu S, Bao R, Wang X, Wu X, Gong W. PMID: 42649595 [PubMed - indexed for MEDLINE]
	Early recurrence prediction after curative-intent surgery of intrahepatic cholangiocarcinoma using a novel weighted tumor burden score. World J Surg Oncol Mantas A, Lueong SS, Mauerer S, Krumm A, Hoyer DP, Amygdalos I, Ulmer TF, Siveke J, Vondran FWR, Neumann UP, Bednarsch J. PMID: 42649504 [PubMed - indexed for MEDLINE]
	Therapeutic strategies and outcomes in the management of ampullary tumours: meta-analysis. BJS Open de Wilde AJ, Faes J, Hermans KEPE, Besselink MG, Fritzsche JA, van Haele M, Poley JW, Voermans RP, De Vos-Geelen J, Olde Damink SWM, Bouwense SAW. PMID: 42647826 [PubMed - indexed for MEDLINE]
	[Cholangiocarcinoma as a model disease: new pathways in personalized medicine]. Dtsch Med Wochenschr Barsch M, Bengsch B. PMID: 42636817 [PubMed - indexed for MEDLINE]
	New progress and clinical research translation of immune checkpoint inhibitors in systemic therapy of gallbladder cancer. Front Immunol Li F, Wang Y, Xu Z, Zhu M, Su K, Yang X, Wu T. PMID: 42626346 [PubMed - indexed for MEDLINE]
	Effect of preoperative body composition on long-term outcomes in patients undergoing distal cholangiocarcinoma resection. Sci Rep Ma Z, Lin Y, Zhang B, Ma Y, Yue P, Yuan J, Li B, Meng W. PMID: 42613374 [PubMed - indexed for MEDLINE]
	Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database Syst Rev Awedew AF, Fentahun Emrie A, Jegnie M, Morales L, supported by the Cochrane Hepato-Biliary Group. PMID: 42605860 [PubMed - indexed for MEDLINE]
	Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis. Arch Iran Med Ejtehadi F, Hashemieh S, Safarpour AR, Shojaei-Zarghani S, Azadnik S, Shamsaeefar A, Rahimikashkooli N. PMID: 42604418 [PubMed - indexed for MEDLINE]
	A TMED3-governed disulfidptosis-related diagnostic signature reveals tumor microenvironment remodeling in intrahepatic cholangiocarcinoma. Front Immunol Qiao W, He Y, Li J, Liu X, Zhang L, Bai X, Wang Y, Tang J. PMID: 42591673 [PubMed - indexed for MEDLINE]
	Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers. Int J Mol Sci Jang HJ, Yim K, Lee SH. PMID: 42589623 [PubMed - indexed for MEDLINE]
	High Expression of SSEA3 and Globo H Predicts Poor Outcomes in Resected Extrahepatic Cholangiocarcinoma: A Single-Center Retrospective Cohort Study. Cancer Med Hung TH, Hung JT, Yeh CN, Hsieh RC, Hsu SC, Yu AL, Huang Y. PMID: 42587395 [PubMed - indexed for MEDLINE]
	Exploratory genomic stratification of benefit from first-line immunotherapy-based combination in advanced biliary tract cancer: a biomarker analysis of a randomized phase 2 trial. Front Immunol He Y, Ruan Z, Xu X, Han Y, Yan J, Ni J, Xu Q, Ying J, Zhou S. PMID: 42577326 [PubMed - indexed for MEDLINE]
	Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma. JCO Precis Oncol Harvey RN, Gelfer R, Drill E, Balachandran V, D'Angelica M, Drebin J, Kingham TP, Saadat L, Soares K, Wei AC, Abou-Alfa GK, Cercek A, Harding JJ, O'Reilly EM, Doukas M, Homs MYV, Groot Koerkamp B, Jarnagin WR. PMID: 42550995 [PubMed - indexed for MEDLINE]
	Exosome-Based Liquid Biopsy in Biliary Tract Cancer: Nanotechnology-Enabled Strategies and Future Perspectives. Int J Nanomedicine Choi Y, Yang J, Kim J, Enkhtaivan K, Son J, Jang J, Lee HY, Choi J. PMID: 42569449 [PubMed - indexed for MEDLINE]
	A Novel Motion-Management Workflow Using Abdominal Compression and Exhale Breath-Hold for Patients With Hepatobiliary Malignancies: A Feasibility Evaluation. Clin Oncol (R Coll Radiol) Webster A, Patel T, Marsh D, Quingua K, Brand D, Clark CH, Hawkins MA. PMID: 42561494 [PubMed - indexed for MEDLINE]
	Therapy-imprinted fibroblast memory in cholangiocarcinoma: rewiring CAF niches for immune evasion and treatment-resistant relapse. Front Immunol Zhang L, Zhang K, Chen Z, Lu X. PMID: 42558642 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 17621

Seite 1 von 882

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung